Contractors, especially on the residential side, rely on their distributors for both purchasing and product information, said ...

Want Early Access & Exclusive Videos? <a href=" to Own it? <a href=" The Parts Of the Story So Far <a href=" us out!▸Twitch - <a href=" - <a href=" - <a href=" - <a href=" - <a href=" - <a href=" ...

Earlier this month, Amgen announced that the FDA approved UPLIZNA (inebilizumab-cdon) for adults with generalized myasthenia ...

The B-cell depleting therapy is indicated for adults with generalized myasthenia gravis and anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibodies.

Archer has also been named the official air taxi provider for the 2028 Los Angeles Olympic Games and is buying the municipal airport in Hawthorne, California, to use as both a Los Angeles hub and test ...

The FDA has approved Uplizna for generalized myasthenia gravis in adults who are anti-AChR and anti-MuSK antibody positive.

Archer is stacking global catalysts fast, from Tokyo to Los Angeles to Saudi Arabia, and a new powertrain revenue stream ...

Order copies of the December 15, 2025, issue of The ACHR NEWS which dives into the tradeoffs as electricity rates and heat pump adaptation are both on the rise, a look at the latest trend report from ...

Archer Aviation Inc. (NYSE:ACHR) is one of the Best Aerospace Stocks to Buy According to Analysts. On December 9, Archer ...

In recent years, five other drugs have been approved to treat gMG, including three complement inhibitors -- eculizumab (Soliris), ravulizumab (Ultomiris), and zilucoplan (Zilbrysq) – and two neonatal ...

The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen’s UPLIZNA ® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...

Amid a swell of regulatory successes in the myasthenia gravis arena this decade, Amgen is wading into the fray with a new ...